A Study on Emergence of Resistance With Oseltamivir (Tamiflu) in Participants With Seasonal Influenza

• Status: Completed
• Trial end date: 2010-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This open-label randomized 2 arm study will determine the emergence of viral resistance in participants with seasonal influenza A infection treated with oseltamivir. Eligible participants less than or equal to () 100.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hoffmann-La Roche
• Treatments: Oseltamivir

Criteria

Inclusion Criteria:

• positive rapid antigen test for influenza A

• onset of symptoms of influenza (fever, at least one respiratory symptom) Exclusion Criteria:

• clinical suspicion of infection with a respiratory virus other than influenza

• suspicion of invasive bacterial infection

• evidence of poorly controlled underlying disease

• known immunosuppression

• known allergy to Oseltamivir

• women who are pregnant or planning to get pregnant during the study